PETALUMA, Calif.--(BUSINESS WIRE)--Dow Pharmaceutical Sciences, Inc., the leading provider of topical formulation development services for prescription products, will present a new poster – “Characterization of Potential Percutaneous Absorption and Penetration Differences of Human Dermatomed Skin and Dermis-Only with Various Receptor Phase Flow Rates, In Vitro, using (3H)-Clotrimazole and (3H)-Hydrocortisone as Model Compounds” at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in Atlanta, Georgia, November 17th-19th.
